instruction
stringlengths
33
156
input
float64
output
stringlengths
120
1.97k
Does Abatacept and Aldesleukin interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Alectinib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Alectinib can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Alemtuzumab interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Alfentanil interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Alfentanil can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Allogeneic processed thymus tissue interact?
null
Allogeneic processed thymus tissue for immune reconstitution therapy aims to restore the immune function of patients with severe immunodeficiency caused by congenital athymia. The concomitant use of immunosuppressive agents may interfere with the therapeutic efficacy of immune reconstitution therapy. In short, The therapeutic efficacy of Allogeneic processed thymus tissue can be decreased when used in combination with Abatacept, and the severity of the interaction is minor.
Does Abatacept and Almotriptan interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Almotriptan can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Alogliptin interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Alogliptin can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Alosetron interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Alosetron can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Alpelisib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Alpelisib can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Alprazolam interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Alprazolam can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Ambrisentan interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Ambrisentan can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Aminophylline interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates with a narrow therapeutic index. In short, The metabolism of Aminophylline can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Amiodarone interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C8 substrates with a narrow therapeutic index. In short, The metabolism of Amiodarone can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Amitriptyline interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates with a narrow therapeutic index. In short, The metabolism of Amitriptyline can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Amodiaquine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C8 substrates. In short, The metabolism of Amodiaquine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Amoxapine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates with a narrow therapeutic index. In short, The metabolism of Amoxapine can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Amphetamine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Amphetamine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Amsacrine interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Amsacrine is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Anagrelide interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates with a narrow therapeutic index. In short, The metabolism of Anagrelide can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Anakinra interact?
null
Anakinra may enhance the adverse effects of Abatacept and increase the risk of infection. A 2006 randomized controlled trial found that abatacept in combination with biologic background therapies was associated with an increase in the rate of serious adverse events and is therefore not recommended for use in combination with biologic therapy. The FDA recommends avoiding concurrent administration of abatacept with other biologic rheumatoid arthritis therapies, such as anakinra. However, a retrospective case series from 2011 of 4 patients with systemic juvenile idiopathic arthritis (sJIA) found this combination to be beneficial to patients with refractory sJIA, "allowing dose reduction of both anakinra and corticosteroids while improving arthritis joint count, as well as controlling systemic features of disease" . Further evidence is needed to confirm this case series and extrapolation to other patient demographics and disease states. In short, The risk or severity of adverse effects can be increased when Anakinra is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Anastrozole interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C8 substrates. In short, The metabolism of Anastrozole can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Anifrolumab interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Anifrolumab, and the severity of the interaction is major.
Does Abatacept and Anthrax immune globulin human interact?
null
Vaccine efficacy may be reduced when immunosuppressant medications are coadministered. Vaccines are designed to elicit an immune response, and this response may be inhibited by immunosuppressants. The administration of live vaccines can also provide a risk as the infection process can be developed due to the immunosuppressive agent. In short, The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Anthrax vaccine interact?
null
Immunosuppressive therapies, including chemotherapy, corticosteroids (used in high-doses longer than 2 weeks), and radiation therapy may reduce the response of the anthrax vaccine BioThrax. In short, The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Abatacept, and the severity of the interaction is minor.
Does Abatacept and Antilymphocyte immunoglobulin (horse) interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Antilymphocyte immunoglobulin (horse), and the severity of the interaction is major.
Does Abatacept and Antipyrine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Antipyrine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Antithymocyte immunoglobulin (rabbit) interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Apalutamide interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C8 substrates. In short, The metabolism of Apalutamide can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Apixaban interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Apixaban can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Apomorphine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2B6 substrates. In short, The metabolism of Apomorphine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Apremilast interact?
null
The concomitant administration of apremilast with biologics for rheumatoid arthritis treatment has not been formally evaluated. Several studies have demonstrated that biologic agents frequently used in the treatment of psoriasis or rheumatoid arthritis may impact the metabolism of hepatic cytochrome enzyme substrates (such as apremilast) by stimulating cytochrome enzyme activities. Apremilast is a CYP3A4 substrate, and induction of this enzyme may lead to decreased therapeutic efficacy resulting from increased metabolism. In short, The therapeutic efficacy of Apremilast can be decreased when used in combination with Abatacept, and the severity of the interaction is major.
Does Abatacept and Aprepitant interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Aprepitant can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Arformoterol interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2A6 substrates. In short, The metabolism of Arformoterol can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Aripiprazole lauroxil interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Aripiprazole lauroxil can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Aripiprazole interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Aripiprazole can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Arsenic trioxide interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Asenapine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Asenapine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Astemizole interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates with a narrow therapeutic index. In short, The metabolism of Astemizole can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and AstraZeneca COVID-19 Vaccine interact?
null
Vaccine efficacy may be reduced when immunosuppressant medications are coadministered. Vaccines are designed to elicit an immune response, and this response may be inhibited by immunosuppressants. The administration of live vaccines can also provide a risk as the infection process can be developed due to the immunosuppressive agent. In short, The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Asunaprevir interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2A6 substrates. In short, The metabolism of Asunaprevir can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Atazanavir interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Atazanavir can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Atenolol interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Atenolol can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Atomoxetine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Atomoxetine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Atorvastatin interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Atorvastatin can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Avacopan interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Avacopan, and the severity of the interaction is major.
Does Abatacept and Avanafil interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Avanafil can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Avapritinib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Avapritinib can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Avatrombopag interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Avatrombopag can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Axitinib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates with a narrow therapeutic index. In short, The metabolism of Axitinib can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Azacitidine interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Azacitidine is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Azathioprine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Azathioprine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Azelastine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Azelastine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Azithromycin interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates. In short, The metabolism of Azithromycin can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Bacillus calmette-guerin substrain russian BCG-I live antigen interact?
null
VERITY-BCG is a live BCG vaccine used in the treatment of bladder cancer. In order to exert its therapeutic effect, intravesically-administered live BCG vaccines require the development of an immune response - its coadministration with immunosuppressive agents, such as the subject drug, may therefore interfere with anti-tumor efficacy by dampening the desired immune response. In short, The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Abatacept, and the severity of the interaction is major.
Does Abatacept and Bacillus calmette-guerin substrain tice live antigen interact?
null
In most cases, the coadministration of live vaccines and immunosuppressive agents is contraindicated due to the risk of uncontrolled replication of the virus and subsequent infection. Drugs capable of causing clinically significant immunosuppression include chemotherapeutic agents (e.g. alkylating agents, antimetabolites), high-dose corticosteroids, and immune mediators/modulators (e.g. TNF-alpha inhibitors). In short, The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Baricitinib interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Baricitinib, and the severity of the interaction is major.
Does Abatacept and Basiliximab interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Basiliximab is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and BCG vaccine interact?
null
In most cases, the coadministration of live vaccines and immunosuppressive agents is contraindicated due to the risk of uncontrolled replication of the virus and subsequent infection. Drugs capable of causing clinically significant immunosuppression include chemotherapeutic agents (e.g. alkylating agents, antimetabolites), high-dose corticosteroids, and immune mediators/modulators (e.g. TNF-alpha inhibitors). In short, The risk or severity of infection can be increased when BCG vaccine is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Beclomethasone dipropionate interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Belatacept interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Belatacept, and the severity of the interaction is major.
Does Abatacept and Belimumab interact?
null
Belimumab is a biologic treatment used for individuals with lupus 2, abatacept is also a biological treatment 1. While being studied, it was found that the use of abatacept with other biologic agents is not safe . The concurrent use of abatacept with another biologic agent may result in an increased incidence of serious infection and neoplasm, and the coadministration is therefore not advised . In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Belimumab, and the severity of the interaction is major.
Does Abatacept and Belinostat interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Belinostat, and the severity of the interaction is major.
Does Abatacept and Belumosudil interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Belumosudil, and the severity of the interaction is major.
Does Abatacept and Belzutifan interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Belzutifan can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Bendamustine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates with a narrow therapeutic index. In short, The metabolism of Bendamustine can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Benzatropine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Benzatropine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Benzocaine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Benzocaine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Benzphetamine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2B6 substrates. In short, The metabolism of Benzphetamine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Benzyl alcohol interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Benzyl alcohol can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Betamethasone interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Betamethasone is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Betaxolol interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Betaxolol can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Bexarotene interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Bexarotene can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Bicalutamide interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Bicalutamide can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Bimekizumab interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Bimekizumab, and the severity of the interaction is major.
Does Abatacept and Binimetinib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates with a narrow therapeutic index. In short, The metabolism of Binimetinib can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Bleomycin interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Bleomycin is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Blinatumomab interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Blinatumomab, and the severity of the interaction is major.
Does Abatacept and Bortezomib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Bortezomib can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Bosentan interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Bosentan can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Bosutinib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Bosutinib can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Brentuximab vedotin interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Brentuximab vedotin can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Brexpiprazole interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Brexpiprazole can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Brigatinib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C8 substrates with a narrow therapeutic index. In short, The metabolism of Brigatinib can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Brivaracetam interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2B6 substrates. In short, The metabolism of Brivaracetam can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Brodalumab interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Brodalumab, and the severity of the interaction is major.
Does Abatacept and Bromazepam interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Bromazepam can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Bromotheophylline interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Bromotheophylline can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Brompheniramine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2B6 substrates. In short, The metabolism of Brompheniramine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Budesonide interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Budesonide is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Bupivacaine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Bupivacaine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Buprenorphine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Buprenorphine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Bupropion interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2B6 substrates. In short, The metabolism of Bupropion can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Buspirone interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Buspirone can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Busulfan interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Busulfan can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Cabazitaxel interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Cabazitaxel can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Cabergoline interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Cabergoline can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Cabozantinib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates with a narrow therapeutic index. In short, The metabolism of Cabozantinib can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Caffeine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Caffeine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Canakinumab interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Canakinumab, and the severity of the interaction is major.
Does Abatacept and Candesartan cilexetil interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Candesartan cilexetil can be increased when combined with Abatacept, and the severity of the interaction is moderate.